Interlink Electronics (LINK) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
12 Jun, 2026Executive summary
Revenue for Q3 2025 increased 10.8% year-over-year to $2.96 million, driven by higher medical and standard product sales, while industrial and automotive revenues declined.
Net loss for Q3 2025 was $336,000, an improvement from a $523,000 loss in Q3 2024, reflecting higher gross profit and reduced R&D expenses.
Gross margin for Q3 2025 was 41.8%, slightly up from 41.4% in Q3 2024, due to favorable product and customer mix.
Completed a 50% common stock dividend and converted all Series A Convertible Preferred Stock into common stock in October 2025, eliminating $400,000 in annual preferred dividends and enhancing liquidity.
Secured two major U.S. government SBIR grants totaling $375,000 for food safety and quality monitoring innovations.
Financial highlights
Q3 2025 revenue: $2.96 million (+10.8% YoY); nine-month revenue: $9.04 million (+4.0% YoY).
Q3 2025 net loss: $336,000; nine-month net loss: $1.04 million.
Q3 2025 gross profit: $1.24 million (41.8% margin); nine-month gross profit: $3.73 million (41.2% margin).
Adjusted EBITDA improved to $(62,000) from $(248,000) year-over-year.
Earnings per share (diluted) improved to $(0.03) from $(0.04) year-over-year.
Outlook and guidance
Management expects existing cash balances to be sufficient for current operations; may seek additional capital if circumstances change.
Entering 2026 with strong momentum, aiming for consistent profitability and scale, focusing on organic growth, strategic partnerships, and expanding M&A pipeline.
Latest events from Interlink Electronics
- Aggressive M&A and organic growth target $100M revenue, backed by innovation and global reach.LINK
Planet MicroCap Las Vegas 202617 Jun 2026 - Q2 2024 saw a 28% revenue drop and net loss, but cost cuts and a strong pipeline support future growth.LINK
Q2 202412 Jun 2026 - Revenue and margins declined on weaker demand, but cash position is strong and no debt remains.LINK
Q3 202412 Jun 2026 - Q1 2025 revenue dropped 14.7% to $2.66M, but strategic wins support a strong 2026 outlook.LINK
Q1 202512 Jun 2026 - Revenue fell and margins compressed, but new acquisitions and grants support future growth.LINK
Q4 202412 Jun 2026 - Q4 2025 saw a 5% revenue decline and a wider net loss, but growth initiatives are underway.LINK
Q4 202512 Jun 2026 - Q2 2025 revenue rose 17.8% year-over-year, gross margin held at 45%, and net income turned positive.LINK
Q2 202512 Jun 2026 - Q1 2026 revenue up 15%, gross margin at 43.5%, net loss narrowed to $338,000, UK expansion planned.LINK
Q1 202612 Jun 2026 - Registering up to $30M in securities for growth, R&D, and strategic flexibility.LINK
Registration filing12 Jun 2026